This inventor holds 1 USPTO granted patent and 1 published patent application and 8 EPO patents. Top assignee: Action Medicines, S.l.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Rosa María Lozano Puerto: Innovator in Medicinal Chemistry
Introduction
Rosa María Lozano Puerto is a distinguished inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of angiodependent diseases. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Rosa María Lozano Puerto holds a patent for the "Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis." This invention focuses on the application of 2,5-dihydroxybenzenesulfonic acid, specifically its calcium and potassium salts, in treating diseases characterized by reduced apoptosis, including cancer and psoriasis. The patent highlights the antiproliferative, antimigratory, antiangiogenic, and proapoptotic properties of these compounds in non-quiescent cells. Furthermore, it details the compounds' potentiating effects on established cytostatic medications in tumor treatment, particularly gliomas, and their therapeutic efficacy in managing chronic psoriatic plaques.
Career Highlights
Rosa María Lozano Puerto has established himself as a key figure in the pharmaceutical industry. His work at Action Medicines, S.L. has been instrumental in advancing research and development in medicinal treatments. His innovative approach and dedication to improving patient outcomes have garnered recognition within the scientific community.
Collaborations
Rosa María collaborates with Antonio Romero Garrido, contributing to the advancement of their shared goals in medicinal chemistry. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in healthcare.
Conclusion
Rosa María Lozano Puerto's contributions to medicinal chemistry, particularly through his patent on 2,5-dihydroxybenzenesulphonic acid, demonstrate his commitment to addressing significant health challenges. His work continues to inspire advancements in the treatment of angiodependent diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile